• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009年癌症统计数据。

Cancer statistics, 2009.

作者信息

Jemal Ahmedin, Siegel Rebecca, Ward Elizabeth, Hao Yongping, Xu Jiaquan, Thun Michael J

机构信息

Cancer Surveillance, Surveillance and Health Policy Research, American Cancer Society, Atlanta, Georgia 30303-1002, USA.

出版信息

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

DOI:10.3322/caac.20006
PMID:19474385
Abstract

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are standardized by age to the 2000 United States standard million population. A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are projected to occur in the United States in 2009. Overall cancer incidence rates decreased in the most recent time period in both men (1.8% per year from 2001 to 2005) and women (0.6% per year from 1998 to 2005), largely because of decreases in the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancer sites in women (breast and colorectum). Overall cancer death rates decreased in men by 19.2% between 1990 and 2005, with decreases in lung (37%), prostate (24%), and colorectal (17%) cancer rates accounting for nearly 80% of the total decrease. Among women, overall cancer death rates between 1991 and 2005 decreased by 11.4%, with decreases in breast (37%) and colorectal (24%) cancer rates accounting for 60% of the total decrease. The reduction in the overall cancer death rates has resulted in the avoidance of about 650,000 deaths from cancer over the 15-year period. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year. Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment.

摘要

美国癌症协会每年都会预估当年美国可能出现的新增癌症病例数和死亡人数,并根据美国国立癌症研究所、疾病控制与预防中心、北美中央癌症登记协会提供的发病率数据以及美国国家卫生统计中心提供的死亡率数据,汇编有关癌症发病率、死亡率和生存率的最新数据。发病率和死亡率按年龄标准化至2000年美国标准百万人口。预计2009年美国将新增1479350例癌症病例,562340人死于癌症。在最近一段时间内,男性(2001年至2005年每年下降1.8%)和女性(1998年至2005年每年下降0.6%)的总体癌症发病率均有所下降,这主要是因为男性三大主要癌症部位(肺癌、前列腺癌以及结肠直肠癌)和女性两大主要癌症部位(乳腺癌和结肠直肠癌)的发病率有所下降。1990年至2005年期间,男性总体癌症死亡率下降了19.2%,其中肺癌(下降37%)、前列腺癌(下降24%)和结肠直肠癌(下降17%)率的下降占总下降幅度的近80%。在女性中,1991年至2005年期间总体癌症死亡率下降了11.4%,其中乳腺癌(下降37%)和结肠直肠癌(下降24%)率的下降占总下降幅度的60%。总体癌症死亡率的降低在15年期间避免了约650000人死于癌症。本报告还按部位、性别、种族/族裔、教育程度、地理区域和历年分析了癌症发病率、死亡率和生存率。尽管在降低发病率和死亡率以及提高生存率方面已取得进展,但在85岁以下人群中,癌症导致的死亡人数仍多于心脏病。通过在全体人群中应用现有的癌症控制知识以及支持癌症预防、早期检测和治疗方面的新发现,可以加快进一步的进展。

相似文献

1
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
4
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
5
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
6
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.《国家癌症报告:第一部分:全国癌症统计数据》
Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22.
7
Cancer statistics, 2005.2005年癌症统计数据。
CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. doi: 10.3322/canjclin.55.1.10.
8
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
9
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
10
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.

引用本文的文献

1
The Evidence That Brain Cancers Could Be Effectively Treated with In-Home Radiofrequency Waves.脑癌可通过家用射频波有效治疗的证据。
Cancers (Basel). 2025 Aug 15;17(16):2665. doi: 10.3390/cancers17162665.
2
Quantitative CT analysis for predicting the PD-L1 expression in lung adenocarcinoma.定量CT分析预测肺腺癌中PD-L1的表达
Jpn J Radiol. 2025 Aug 26. doi: 10.1007/s11604-025-01857-8.
3
Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model.
不可逆电穿孔与同种异体嵌合抗原受体(CAR)T细胞疗法的新型联合方案在临床前人类胰腺癌小鼠模型中可增强治疗效果。
bioRxiv. 2025 Aug 12:2025.08.10.669537. doi: 10.1101/2025.08.10.669537.
4
A handheld microfluidic manifold for massively multiplexed CRISPR-based nucleic acid detection.一种用于基于CRISPR的大规模多重核酸检测的手持式微流控歧管。
bioRxiv. 2025 Aug 12:2025.08.11.669785. doi: 10.1101/2025.08.11.669785.
5
OUTCOME-GUIDED DISEASE SUBTYPING BY GENERATIVE MODEL AND WEIGHTED JOINT LIKELIHOOD IN TRANSCRIPTOMIC APPLICATIONS.转录组学应用中基于生成模型和加权联合似然性的结果导向疾病亚型分类
Ann Appl Stat. 2024 Sep;18(3):1947-1964. doi: 10.1214/23-aoas1865. Epub 2024 Aug 5.
6
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201.5-氟尿嘧啶生物标志物表达与接受S-1辅助化疗的老年肺癌患者衰老及预后的相关性:濑户内肺癌研究组1201研究的随访结果
Mol Clin Oncol. 2025 Jul 3;23(3):79. doi: 10.3892/mco.2025.2874. eCollection 2025 Sep.
7
Bibliometric and Visualized Analysis of Artemisinin and Its Derivatives in Cancer.青蒿素及其衍生物在癌症研究中的文献计量学与可视化分析
Drug Des Devel Ther. 2025 Jun 30;19:5517-5538. doi: 10.2147/DDDT.S514219. eCollection 2025.
8
Associations of Type 2 Diabetes with risk of overall and site-specific cancers in a cohort of predominantly low-income racially diverse populations.在一个主要为低收入、种族多样人群的队列中,2型糖尿病与总体癌症及特定部位癌症风险的关联。
Cancer Epidemiol Biomarkers Prev. 2025 Jun 25. doi: 10.1158/1055-9965.EPI-23-1079.
9
Case Report: First case of low-grade myofibroblastic sarcoma of the vulva during pregnancy.病例报告:孕期外阴低度肌成纤维细胞肉瘤首例。
Front Oncol. 2025 Jun 10;15:1577068. doi: 10.3389/fonc.2025.1577068. eCollection 2025.
10
Clinical utility of GAL-8, ITGΒ-1, and HIF-1α as non-invasive diagnostic and prognostic biomarkers for assessing glioma.GAL-8、ITGΒ-1和HIF-1α作为评估神经胶质瘤的非侵入性诊断和预后生物标志物的临床效用。
J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05110-0.